Status:
COMPLETED
Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer
Lead Sponsor:
SCRI Development Innovations, LLC
Collaborating Sponsors:
Institutional Review Board TriStar Nashville Market
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
In this phase II trial, we will evaluate the weekly schedule of topotecan in the first-line treatment of elderly and/or poor performance status patients with extensive stage small cell lung cancer. Pa...
Detailed Description
Upon determination of eligibility, all patients will be receive: * Topotecan
Eligibility Criteria
Inclusion
- To be included in this study, you must meet the following criteria:
- Biopsy-proven small cell lung cancer, extensive stage disease
- Age \> 65 years
- No previous chemotherapy or radiation therapy.
- Measurable or evaluable disease.
- Adequate bone marrow, liver and kidney function.
- Must be \> 4 weeks from previous major surgery
- Must give written informed consent prior to study entry.
Exclusion
- You cannot participate in this study if any of the following apply to you:
- Meningeal involvement
- Serious active infections
- Serious underlying medical conditions
- Other active neoplasms
- Please note: There are additional inclusion/exclusion criteria. The study center will determine if you meet all of the criteria. If you do not qualify for the trial, study personnel will explain the reasons. If you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
Key Trial Info
Start Date :
August 1 2002
Trial Type :
INTERVENTIONAL
End Date :
November 1 2004
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00193401
Start Date
August 1 2002
End Date
November 1 2004
Last Update
July 28 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.